These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24792777)

  • 1. Neonatal drug trials: impact of EU and US paediatric regulations.
    Pansieri C; Bonati M; Choonara I; Jacqz-Aigrain E
    Arch Dis Child Fetal Neonatal Ed; 2014 Sep; 99(5):F438. PubMed ID: 24792777
    [No Abstract]   [Full Text] [Related]  

  • 2. A critique of emerging European legislation in the pharmaceutical industry: a clinical trials analysis.
    Murray E; McAdam R; Burke MT
    Int J Health Care Qual Assur Inc Leadersh Health Serv; 2004; 17(7):389-93. PubMed ID: 15552394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K
    Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EU law mandates drug testing in children.
    Sinha G
    J Natl Cancer Inst; 2008 Jan; 100(2):84-5. PubMed ID: 18182609
    [No Abstract]   [Full Text] [Related]  

  • 5. The EU paediatric regulation: effects on paediatric psychopharmacology in Europe.
    Stoyanova-Beninska VV; Wohlfarth T; Isaac M; Kalverdijk LJ; van den Berg H; Gispen-de Wied C
    Eur Neuropsychopharmacol; 2011 Aug; 21(8):565-70. PubMed ID: 20621456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug policy in Europe Research and funding in neonates: current challenges, future perspectives, new opportunities.
    Jacqz-Aigrain E
    Early Hum Dev; 2011 Mar; 87 Suppl 1():S27-30. PubMed ID: 21269785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EU directive on clinical trials penalizes small sponsors.
    Meldolesi A
    Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
    [No Abstract]   [Full Text] [Related]  

  • 8. New European regulation for clinical trials of medicinal products.
    Lemaire F; Matei M; Juvin P
    Am J Respir Crit Care Med; 2015 Jan; 191(1):16-8. PubMed ID: 25551347
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug company drops case after EMA agrees to redactions in some documents to be published.
    Dyer C
    BMJ; 2014 Apr; 348():g2632. PubMed ID: 24709373
    [No Abstract]   [Full Text] [Related]  

  • 10. Japanese abandon domestic trials.
    Saegusa A
    Nat Biotechnol; 1998 Oct; 16(10):898-9. PubMed ID: 9788333
    [No Abstract]   [Full Text] [Related]  

  • 11. The future of neonatal therapeutic trials.
    Stephenson T; Budge H
    Arch Dis Child Fetal Neonatal Ed; 2006 Jul; 91(4):F305-7. PubMed ID: 16790737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Researchers see a need for speed in EU trial approvals.
    Cressey D
    Nat Med; 2008 Aug; 14(8):794. PubMed ID: 18685580
    [No Abstract]   [Full Text] [Related]  

  • 13. Paediatric research should take centre stage.
    Lancet; 2004 Aug 28-Sep 3; 364(9436):732. PubMed ID: 15337381
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharma's commitment to maintaining a clinical trial register: increased transparency or contrived public appeasement?
    Falit B
    J Law Med Ethics; 2005; 33(2):391-6. PubMed ID: 16083099
    [No Abstract]   [Full Text] [Related]  

  • 15. Globalization of clinical research by the pharmaceutical industry.
    Shah S
    Int J Health Serv; 2003; 33(1):29-36. PubMed ID: 12641261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences with GLP/GCP from the pharmaceutical industry's viewpoint.
    Legler UF
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):233-6. PubMed ID: 8361261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European ombudsman questions European Medicines Agency over AbbVie redactions.
    Watson R
    BMJ; 2014 Nov; 349():g6904. PubMed ID: 25406123
    [No Abstract]   [Full Text] [Related]  

  • 18. [Research using medication. The regulatory norms must be respected].
    Gómez de la Cámara A
    Aten Primaria; 2003 Jan; 31(1):3-5. PubMed ID: 12570893
    [No Abstract]   [Full Text] [Related]  

  • 19. The socio-political roots of pharmaceutical uncertainty in the evaluation of 'innovative' diabetes drugs in the European Union and the US.
    Davis C; Abraham J
    Soc Sci Med; 2011 May; 72(9):1574-81. PubMed ID: 21474222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing medications in children.
    Gurwitz JH
    N Engl J Med; 2003 Feb; 348(8):763-4; author reply 763-4. PubMed ID: 12596752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.